semaglutide patent expiration date us Last week's expiry of the for semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions Looming GLP-1 drug patent expirations

In patients with poorly controlled T2D, 6 months of treatment with liraglutide 1.2 mg/day significantly reduced liver fat content as evaluated by 1 H-magnetic resonance spectroscopy, an effect mainly driven by bodyweight loss (65)

Many of these therapies also support once-weekly or even once-monthly dosing, enhancing adherence in populations where polypharmacy or injection fatigue is a concern

K., Shenouda, S

In addition to its requisite role in fatty acid oxidation, it can facilitate glucose disposal by modifying the mitochondrial acetyl-CoA/CoA ratio [8]

After that, your dose may be increased by 0.5mg every 4 weeks up to 2 mg once weekly, depending on how you respond to the medication For weight purposes, its important to follow medical advice, but generally, dosages should not exceed the maintenance dose of 2 mg once weekly, as this is considered the upper limit for safe use